ArticleDigestive diseases and sciences2026
Single-Cell Transcriptomics Dissects the Molecular Mechanism by Which Macrophage Polarization Drives Hepatocellular Carcinoma Metastasis Through Crosstalk with Emt-Tumor Microenvironment.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatocellular carcinoma (HCC) is a highly heterogeneous malignancy whose progression is tightly linked to the immunosuppressive tumor microenvironment (TME). Tumor-associated macrophages (TAMs), central regulatory components of the TME, foster HCC metastasis by mediating immune evasion and epithelial-mesenchymal transition (EMT). The underlying molecular mechanisms remain to be elucidated. Clarifying how TAM polarization intersects with EMT will provide a rational basis for targeted HCC therapies.
methodsWe integrated scRNA-seq and copy-number variation profiling to delineate TAM subpopulations. CellChat was employed to construct cell-cell communication networks and screen for pivotal TAM-EMT signals. Expression and prognostic relevance of key molecules were validated in the TCGA-LIHC cohort. qRT-PCR, WB, Transwell, CCK-8, and flow cytometry were used for functional characterization.
resultsscRNA-seq resolved eight major cell types, including T/NK cells, epithelial cells, macrophages, monocytes, endothelial cells, fibroblasts, B cells, and dendritic cells. Four TAM subpopulations were identified, among which M2-like macrophages dominated both primary and metastatic HCC lesions. Cell-cell communication analysis revealed that M2-like macrophages engaged epithelial cells via the SPP1-(ITGA5 + ITGB1) signaling. According to clinical data, the activity of this signaling correlated with poor prognosis in HCC patients. Functional assays confirmed that knocking down ITGA5 reversed M2 macrophage polarization and suppressed HCC cell proliferation, apoptosis resistance, migration, and invasion.
conclusionsITGA5 is a master regulator of the pro-tumorigenic functions of TAMs. The SPP1-(ITGA5 + ITGB1) signaling represents a novel immunotherapeutic target in HCC. Targeting TAM polarization may reprogram the immunosuppressive microenvironment and improve patient outcomes.
Indexed as
Identifiers
42032376What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.